Alt
260A
Shin-Etsu Chemical
4063
Metaplanet
3350
4
Astellas Pharma
4503
5
Mitsubishi
8058
JP Stock MarketDetailed Quotes
4503 Astellas Pharma
- 1381.5
- +21.0+1.54%
20min DelayMarket Closed Apr 25 15:30 JST
2.50TMarket Cap48.92P/E (Static)
1388.5High1366.5Low5.52MVolume1374.0Open1360.5Pre Close7.60BTurnover1835.052wk High0.32%Turnover Ratio1.81BShares1243.552wk Low28.24EPS TTM2.39TFloat Cap2360.5Historical High48.92P/E (Static)1.73BShs Float540.0Historical Low28.24EPS LYR1.62%Amplitude74.00Dividend TTM1.63P/B100Lot Size5.36%Div YieldTTM
Astellas Pharma Key Stats
EPS
According to the latest financial report of Astellas Pharma, the latest earnings per share (TTM) for the company is 20.94. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Astellas Pharma's free cash flow? The latest report shows it as -14.70B. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Astellas Pharma shows that the company's current ratio is 1.13, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Astellas Pharma, the quick ratio is 0.80, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Astellas Pharma? The latest ROE figure is -2.15%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Astellas Pharma, the total asset return on investment (ROA) is -0.96%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Astellas Pharma's latest financial report to see how their gross margin is doing - currently at 80.74%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Astellas Pharma, the net profit margin is 7.95%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...